1-3 of 3
Lisa Nodzon, PhDANP
Close
Sort by
Journal Articles

Mutational Landscape of Chronic Lymphocytic Leukemia Using Next Generation Sequencing Technologies in the Real World Clinical Setting

Jose D Sandoval-Sus, MD, Facundo E. Stingo, MD, Todd C. Knepper, PharmD, Lisa Nodzon, PhDANP, Eric Padron, MD, Mohamed A Kharfan-Dabaja, MD, Julio C. Chavez, MD, Javier Pinilla-Ibarz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4366.
https://doi.org/10.1182/blood.V128.22.4366.4366
Published: 2016
Journal Articles

Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

Javier Pinilla-Ibarz, Julio C Chavez, MD, Elyce Turba, RN, MSN, OCN, Lisa Nodzon, PhDANP, Jennifer rock-Klotz, BA, Samir Dalia, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Celeste M. Bello, MD
Journal: Blood
Blood (2015) 126 (23): 2941.
https://doi.org/10.1182/blood.V126.23.2941.2941
Published: 2015
Journal Articles

Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience

Jose D Sandoval-Sus, MD, Julio C Chavez, MD, Samir Dalia, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Viet Q. Ho, PharmD, RPh, BCOP, Lisa Nodzon, PhDANP, Mohamed A. Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, MD PhD, Javier Pinilla-Ibarz
Journal: Blood
Blood (2015) 126 (23): 2945.
https://doi.org/10.1182/blood.V126.23.2945.2945
Published: 2015